POLYARTICULAR JUVENILE IDIOPATHIC ARTHRITIS
Clinical trials for POLYARTICULAR JUVENILE IDIOPATHIC ARTHRITIS explained in plain language.
Never miss a new study
Get alerted when new POLYARTICULAR JUVENILE IDIOPATHIC ARTHRITIS trials appear
Sign up with your email to follow new studies for POLYARTICULAR JUVENILE IDIOPATHIC ARTHRITIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Engineered immune cells take on childhood arthritis and autoimmune diseases
Disease control Recruiting nowThis study is testing a new treatment using specially engineered immune cells (CAR-T cells) in children aged 5 and older with severe rheumatic diseases like juvenile dermatomyositis, arthritis, systemic sclerosis, and Sjögren's syndrome that haven't improved with standard therapi…
Matched conditions: POLYARTICULAR JUVENILE IDIOPATHIC ARTHRITIS
Phase: PHASE1 • Sponsor: Chongqing Precision Biotech Co., Ltd • Aim: Disease control
Last updated May 25, 2026 05:04 UTC
-
New study tracks arthritis drug safety in kids
Disease control Recruiting nowThis study watches how safe and effective Xeljanz is for children aged 2 to 17 with active juvenile arthritis or psoriatic arthritis in everyday Korean clinics. About 10 kids will be followed for up to 44 weeks. The goal is to check for side effects and see how well the medicine …
Matched conditions: POLYARTICULAR JUVENILE IDIOPATHIC ARTHRITIS
Sponsor: Pfizer • Aim: Disease control
Last updated May 19, 2026 11:49 UTC